Latest News

While we enjoy watching the progress our portfolio companies make, we appreciate this does not come easily and requires large measures of expertise, intuition, ingenuity and perseverance. This understanding increases our satisfaction in bringing you news of their accomplishments.

Use the filters above to refine results
23rd October 2018

Abingworth appoints Jackie Grant as Principal

18th October 2018

GenSight Biologics reports positive 72-week data from REVERSE Phase III clinical trial of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON)

11th October 2018

CRISPR Therapeutics and Vertex Announce FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease

9th October 2018

Personalis Receives New Order from the VA’s Million Veteran Program – Total Contracted Now Almost 80,000 Whole Human Genomes

3rd October 2018

Paratek Announces FDA Approval of NUZYRA™ (Omadacycline)

3rd October 2018

FDA Approves SEYSARA™ (Sarecycline) for the Treatment of Moderate to Severe Acne

28th September 2018

US FDA Approves VIZIMPRO® (dacomitinib) for the First-Line Treatment of Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer

25th September 2018

VenatoRx Pharmaceuticals and Everest Medicines II Limited Announce Exclusive License Agreement for cefepime/VNRX-5133

21st September 2018

Abingworth appoints Brian Gallagher, Jr as Partner

17th September 2018

Virion Appoints Vanessa King as President & CEO and Isabel Najera as CSO

22nd August 2018

Gynesonics Receives FDA Clearance to Market Sonata® System

8th August 2018

FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline

19th July 2018

IFM Therapeutics, LLC Launches Subsidiary, IFM Tre, with $31 Million Series A Financing to Develop NLRP3 Antagonists for Inflammatory Diseases

9th July 2018

Abingworth raises $315m for ABV VII - 12th life sciences fund

20th June 2018

IFM Therapeutics, LLC Appoints World-Renowned Physicians and Researchers to Clinical Advisory Board

7th June 2018

SutroVax Announces $85M Series C Financing led by TPG Growth

4th June 2018

Dacomitinib Shows More than Seven-Month Improvement in Overall Survival Compared to an Established Therapy in Advanced NSCLC with EGFR-Activating Mutations

30th May 2018

CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease

3rd May 2018

Sientra Announces Pricing of Upsized Public Offering of Common Stock

2nd May 2018

Avedro Announces $25 Million in Funding to Fuel Innovation and Commercial Growth

30th April 2018

Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough

26th April 2018

Lombard Medical Acquired by MicroPort Scientific Corporation in a Restructuring Transaction

23rd April 2018

MYLOTARG™ Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy

18th April 2018

Sientra Receives FDA Approval of PMA Supplement

11th April 2018

Alexion to Acquire Wilson Therapeutics

10th April 2018

Pfizer Provides Update on Phase 3 Trial of Axitinib as Adjuvant Treatment for Patients at High Risk of Renal Cell Carcinoma Recurrence After Surgery

4th April 2018

U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib to Treat Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations

4th April 2018

Paratek’s New Drug Applications for Oral and Intravenous Omadacycline Accepted for Priority Review by FDA

3rd April 2018

GenSight Biologics announces topline results from REVERSE Phase III clinical trial of GS010 in patients with Leber Hereditary Optic Neuropathy (LHON)

27th March 2018

IFM Co-Founder Dr. Eicke Latz Receives 2018 Leibniz Prize

26th March 2018

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

13th March 2018

Avillion Signs Co-Development Agreement with Pearl Therapeutics Inc. (part of AstraZeneca) to Conduct Clinical Development of PT027 in Asthma

2nd March 2018

Verona Pharma Reports Positive Top-Line Data from Phase 2a Trial with RPL554 in Cystic Fibrosis Patients

23rd February 2018

Pfizer Receives Positive CHMP Opinion for Two Hematology Medicines, MYLOTARG™ and BOSULIF®

21st February 2018

MSD and Viralytics Announce Acquisition Agreement, Expanding MSD’s Leading Immuno-Oncology Pipeline

16th February 2018

First patient enrolled in pivotal Phase 3 FOCuS trial evaluating WTX101 for the treatment of Wilson Disease

12th February 2018

Labcyte Acoustic Liquid Handlers Named Top Product in Lab Automation Conference Awards

25th January 2018

Pixium Vision completes World’s First Successful Activation in Human of PRIMA Bionic Vision System

18th January 2018

Paratek Announces Pricing of Public Offering of Common Stock

10th January 2018

GenSight Biologics receives MHRA approval to initiate Phase I/II PIONEER clinical trial of GS030 gene therapy in Retinitis Pigmentosa

9th January 2018

Gynesonics announces results from pivotal IDE trial for incision free treatment for Uterine Fibroids